Apiaceae Essential Oils: Boosters of Terbinafine Activity against Dermatophytes and Potent Anti-Inflammatory Effectors.

Adriana Trifan, Simon Vlad Luca, Andra-Cristina Bostănaru, Mihai Brebu, Alexandra Jităreanu, Romeo-Teodor Cristina, Krystyna Skalicka-Woźniak, Sebastian Granica, Monika E Czerwińska, Aleksandra Kruk, Hélène Greige-Gerges, Elwira Sieniawska, Mihai Mareș
Author Information
  1. Adriana Trifan: Department of Pharmacognosy, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania. ORCID
  2. Simon Vlad Luca: Department of Pharmacognosy, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
  3. Andra-Cristina Bostănaru: Laboratory of Antimicrobial Chemotherapy, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 700489 Iasi, Romania.
  4. Mihai Brebu: Physical Chemistry of Polymers Laboratory, Petru Poni Institute of Macromolecular Chemistry, 700481 Iasi, Romania. ORCID
  5. Alexandra Jităreanu: Department of Toxicology, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
  6. Romeo-Teodor Cristina: Department of Pharmacology, The Banat University of Agricultural Sciences and Veterinary Medicine, 300645 Timisoara, Romania. ORCID
  7. Krystyna Skalicka-Woźniak: Department of Natural Products Chemistry, Medical University of Lublin, 20-093 Lublin, Poland. ORCID
  8. Sebastian Granica: Microbiota Lab, Centre for Preclinical Studies, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, 02-097 Warsaw, Poland. ORCID
  9. Monika E Czerwińska: Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. ORCID
  10. Aleksandra Kruk: Microbiota Lab, Centre for Preclinical Studies, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, 02-097 Warsaw, Poland.
  11. Hélène Greige-Gerges: Bioactive Molecules Research Laboratory, Department of Chemistry and Biochemistry, Faculty of Sciences, Section II, Lebanese University, Jdaidet el-Matn B.P. 90656, Lebanon. ORCID
  12. Elwira Sieniawska: Department of Natural Products Chemistry, Medical University of Lublin, 20-093 Lublin, Poland. ORCID
  13. Mihai Mareș: Laboratory of Antimicrobial Chemotherapy, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 700489 Iasi, Romania. ORCID

Abstract

Dermatophyte infections represent an important public health concern, affecting up to 25% of the world's population. and are the predominant dermatophytes in cutaneous infections, with a prevalence accounting for 70% of dermatophytoses. Although terbinafine represents the preferred treatment, its clinical use is hampered by side effects, drug-drug interactions, and the emergence of resistant clinical isolates. Combination therapy, associating terbinafine and essential oils (EOs), represents a promising strategy in the treatment of dermatophytosis. In this study, we screened the potential of selected Apiaceae EOs (ajowan, coriander, caraway, and anise) to improve the antifungal activity of terbinafine against ATCC 28188 and ATCC 9533. The chemical profile of EOs was analyzed by gas chromatography. The minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of EOs/main compounds were determined according to EUCAST-AFST guidelines, with minor modifications. The checkerboard microtiter method was used to identify putative synergistic combinations of EOs/main constituents with terbinafine. The influence of EOs on the viability and pro-inflammatory cytokine production (IL-1, IL-8 and TNF-) was determined using an ex vivo human neutrophils model. The binary associations of tested EOs with terbinafine were found to be synergistic against , with FICI values of 0.26-0.31. At the tested concentrations (6.25-25 mg/L), EOs did not exert cytotoxic effects towards human neutrophils. Anise EO was the most potent inhibitor of IL-1 release (46.49% inhibition at 25 mg/L), while coriander EO displayed the highest inhibition towards IL-8 and TNF- production (54.15% and 54.91%, respectively). In conclusion, the synergistic combinations of terbinafine and investigated Apiaceae EOs could be a starting point in the development of novel topical therapies against -related dermatophytosis.

Keywords

References

  1. Avicenna J Phytomed. 2016 Mar-Apr;6(2):205-14 [PMID: 27222834]
  2. Molecules. 2013 Jan 18;18(1):1227-54 [PMID: 23334570]
  3. Evid Based Complement Alternat Med. 2016;2016:3012462 [PMID: 28090211]
  4. Expert Rev Clin Pharmacol. 2017 Feb;10(2):225-237 [PMID: 27868472]
  5. J Pharm Pharmacol. 2018 Sep;70(9):1216-1227 [PMID: 29956331]
  6. Molecules. 2019 Oct 15;24(20): [PMID: 31619024]
  7. Mycopathologia. 2017 Feb;182(1-2):5-31 [PMID: 27783317]
  8. Antimicrob Agents Chemother. 2019 Sep 23;63(10): [PMID: 31383665]
  9. Nat Prod Res. 2017 Feb;31(4):460-464 [PMID: 27309978]
  10. Food Funct. 2019 Sep 1;10(9):6135-6146 [PMID: 31497826]
  11. J Eur Acad Dermatol Venereol. 2013 Mar;27(3):287-94 [PMID: 22181693]
  12. Food Funct. 2020 Sep 23;11(9):7946-7959 [PMID: 32832941]
  13. Molecules. 2020 Nov 26;25(23): [PMID: 33256033]
  14. Immunology. 1987 Jul;61(3):289-95 [PMID: 3610211]
  15. J Surg Res. 2013 Mar;180(1):e47-54 [PMID: 23228323]
  16. Adv Wound Care (New Rochelle). 2013 Sep;2(7):389-399 [PMID: 24527355]
  17. Front Immunol. 2020 Dec 02;11:605644 [PMID: 33343578]
  18. Nat Rev Immunol. 2011 Apr;11(4):275-88 [PMID: 21394104]
  19. Res Pharm Sci. 2013 Jan;8(1):1-8 [PMID: 24459470]
  20. Mycopathologia. 2016 Feb;181(1-2):9-15 [PMID: 26481920]
  21. Front Microbiol. 2020 Jul 14;11:1593 [PMID: 32760372]
  22. J Ethnopharmacol. 2020 Nov 15;262:113169 [PMID: 32739565]
  23. Rev Med Chir Soc Med Nat Iasi. 2011 Oct-Dec;115(4):1271-7 [PMID: 22276482]
  24. Lett Appl Microbiol. 2018 Nov;67(5):449-457 [PMID: 30187508]
  25. Biomed Res Int. 2017;2017:9268468 [PMID: 29230418]
  26. Rev Med Chir Soc Med Nat Iasi. 2016 Jul-Sep;120(3):732-6 [PMID: 30152663]
  27. Fungal Genet Biol. 2019 Nov;132:103255 [PMID: 31330295]
  28. Molecules. 2017 Sep 22;22(10): [PMID: 28937623]
  29. Acta Trop. 2013 Oct;128(1):110-5 [PMID: 23850505]
  30. J Infect Chemother. 2006 Aug;12(4):210-6 [PMID: 16944261]
  31. Chem Biol Interact. 2018 Mar 1;283:97-106 [PMID: 29427589]
  32. J Appl Microbiol. 2020 Aug;129(2):212-232 [PMID: 32048417]
  33. Crit Rev Microbiol. 2020 May;46(3):338-357 [PMID: 32608293]
  34. Mycoses. 2019 Apr;62(4):336-356 [PMID: 30561859]
  35. Med Mycol. 2020 Aug 1;58(6):707-720 [PMID: 31773153]
  36. Pharmacogn Rev. 2012 Jan;6(11):56-60 [PMID: 22654405]
  37. Fitoterapia. 2018 Jun;127:115-122 [PMID: 29447978]
  38. Pharm Biol. 2011 Jul;49(7):679-86 [PMID: 21517705]
  39. Braz J Microbiol. 2014 Aug 29;45(2):523-31 [PMID: 25242937]
  40. Immunol Lett. 2016 Oct;178:3-9 [PMID: 27262927]
  41. Int Immunopharmacol. 2015 Dec;29(2):708-713 [PMID: 26432179]
  42. Am J Clin Dermatol. 2021 Mar;22(2):149-157 [PMID: 33354740]
  43. Fitoterapia. 2015 Jun;103:9-26 [PMID: 25776008]
  44. Planta Med. 2011 Jul;77(11):1168-82 [PMID: 21283954]
  45. Mycopathologia. 2017 Feb;182(1-2):143-167 [PMID: 27771883]
  46. Med Mycol. 2020 Feb 1;58(2):272-274 [PMID: 31329906]
  47. J Fungi (Basel). 2021 Sep 05;7(9): [PMID: 34575765]
  48. Br J Dermatol. 2017 Nov;177(5):1279-1284 [PMID: 28762471]
  49. J Fungi (Basel). 2018 Jul 24;4(3): [PMID: 30042327]
  50. Biomed Pharmacother. 2017 Jul;91:925-930 [PMID: 28511344]
  51. J Mycol Med. 2017 Jun;27(2):195-202 [PMID: 28189377]
  52. Food Chem Toxicol. 2008 Feb;46(2):446-75 [PMID: 17996351]

Grants

  1. 7246/12.04.2018/Grigore T. Popa University of Medicine and Pharmacy
  2. PN-III-P1-1.1-MC-2019-1056/Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii

Word Cloud

Created with Highcharts 10.0.0terbinafineEOsApiaceaesynergisticinfectionsrepresentstreatmentclinicaleffectsessentialdermatophytosiscorianderATCCminimalconcentrationEOs/maindeterminedcheckerboardcombinationsproductionIL-1IL-8TNF-humanneutrophilstestedmg/LtowardsEOinhibition54Dermatophyterepresentimportantpublichealthconcernaffecting25%world'spopulationpredominantdermatophytescutaneousprevalenceaccounting70%dermatophytosesAlthoughpreferredusehamperedsidedrug-druginteractionsemergenceresistantisolatesCombinationtherapyassociatingoilspromisingstrategystudyscreenedpotentialselectedajowancarawayaniseimproveantifungalactivity281889533chemicalprofileanalyzedgaschromatographyinhibitoryMICfungicidalMFCcompoundsaccordingEUCAST-AFSTguidelinesminormodificationsmicrotitermethodusedidentifyputativeconstituentsinfluenceviabilitypro-inflammatorycytokineusingexvivomodelbinaryassociationsfoundFICIvalues026-031concentrations625-25exertcytotoxicAnisepotentinhibitorrelease4649%25displayedhighest15%91%respectivelyconclusioninvestigatedstartingpointdevelopmentnoveltopicaltherapies-relatedEssentialOils:BoostersTerbinafineActivityDermatophytesPotentAnti-InflammatoryEffectorsCarumcarviCoriandrumsativumPimpinellaanisumTrachyspermumammiTrichophytonrubrumassaycytokinesoilsynergy

Similar Articles

Cited By